US Patent 8591897 Anti-ERBB2 antibody adjuvant therapy
Patent 8591897 was granted and assigned to Genentech on November, 2013 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 6, 2006
Date of Patent
November 26, 2013
Patent Application Number
11400638
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8591897 Anti-ERBB2 antibody adjuvant therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.